Our Diverse Research Portfolio Promotes Enhanced Care

Infectious Diseases

The Division of Infectious Diseases reflects the multidisciplinary approach essential to the practice of medicine and medical research. Our faculty are involved in patient care, infection prevention and control, basic science, clinical research activities, antimicrobial stewardship, outcomes analysis, clinical trials, and teaching.
Division members have diverse and interrelated interests ranging from very basic mechanisms of molecular pathogenesis to the cascades of care required to ensure that adolescents receive appropriate treatment for sexually transmitted infections (STIs).
We are actively engaged in medical education with undergraduate, graduate, medical, and postdoctoral students from all of Columbia's health sciences divisions, as well as in basic science education, with two current PhD postdoctoral fellows, one PhD candidate, and three active Columbia College undergraduates in the lab.
Along with our colleagues in adult ID and pharmacy, we actively review antimicrobial usage and trends in bacterial susceptibility to develop algorithms to guide appropriate and effective antibiotic use. We strive to not only provide optimal clinical care for children with infectious diseases but to understand the pathogenesis of these infections and to implement the most effective strategies to prevent them.
New Programs
- Transplant ID - PITCH - Over the past year, we have developed a full-fledged “PITCH” service – Pediatric Transplant and Immunocompromised Host service headed by Paul Sue, MD, and recently joined by Sanya Thomas, MD, with rotating fellows, residents, and students. As our transplant population increases and expands to include patients with genetic disorders as well as cardiac and liver abnormalities, we have many patients with enhanced susceptibility to infection. These patients, in addition to those receiving stem cell transplantation for malignancies, require dedicated ID specialists. We are actively growing this subspecialty within Peds ID, with the goal of having a dedicated Peds Transplant ID sub-specialty fellowship in the future.
- Development of Clinical Workflows – We are eager to exploit the technological advances provided by AI to ID, a data-driven subspecialty. Jason Zucker, MD, is collaborating with the Department of Biomedical Informatics (DBMI) to integrate generative AI into clinical workflows, focusing on chart summarization. The goal is to streamline the review of electronic health records (EHRs) by using AI to generate concise, accurate summaries of patient charts. This tool is particularly helpful in pediatric care, where longitudinal data often spans many years and involves multiple providers.
- Antibiotic Stewardship in Pediatrics – Antimicrobial resistance is a major issue in the practice of pediatrics at all levels. Irene Frantzis, MD, is directing our ASP (antimicrobial stewardship) program with new projects to gather data regarding rates of fungal disease and usage of anti-fungal medication, a growing and important area of concern. Dr. Frantzis is actively updating recommendations for surgical prophylaxis and guidelines specifically for cardiac surgery. We are also launching programs to study laboratory utilization, the use of non-culture pathogen detection through Karius, and importantly, the judicious use of specific lab tests to most efficiently diagnose C.diff infection and UTIs.
New Appointments
- Sanya Thomas, MD,
- Assistant Professor of Pediatrics at CUMC
New Leadership Positions
- Natalie Neu, MD, MPH
- Medical Director for the NYC Prevention Training Center
- Associate Director for the Clinical research resource of the CTSA
- Multi-Principal Investigators: Espinal and Alwyn Cohall, MD; Medical Director: Natalie Neu, MD, MPH
- Project STAY (Program to Assist Youth) Youth Access Program. New York State Department of Health AIDS Institute. C027235B.
- Principal Investigator: Alwyn Cohall, MD, Natalie Neu, MD, MPH; Medical Director: Natalie Neu, MD, MPH.
- National Network of Sexually Transmitted Diseases Clinical Prevention Training Centers (NNPTC). CDC. 1NU62PS924586.
National Committees
- Sanya Thomas, MD
- Executive Member, Workforce Development Committee, Pediatric Infectious Diseases Society 01/2024-present
- Executive Member, Training Programs Committee, Pediatric Infectious Diseases Society 01/2022-present
- Co-Chair, Education Subcommittee, Pediatric Community of Practice (PCOP), American Society of Transplant (AST) 01/2023-05/2026
- Member, ABP’s Infectious Diseases Milestones 2.0 to EPAs Mapping Project 05/2023-present
- Executive member, Infectious Disease Clinical Care, Advocacy, Research, and Education (ID CARE) Committee, International Pediatric Transplant Association (IPTA) 05/2023-05/2025
- Member-at-Large, PCOP-Executive Committee, AST 05/2023-05/2026
- Jason Zucker, MD, MS
- HIV Glasgow 2024 Scientific Committee 6/2024 – 10/2024
- CDC’s Sexually Transmitted Infections (STI) Treatment Guidelines. Centers for Disease Control and Prevention. Medical Consultant: Jason Zucker, MD, MS.
Awards
- Jason Zucker, MD, MS
- Linda Laubenstein Award – Presented by the New York State Department of Health AIDS Institute and honors physicians who, beyond providing the highest quality of clinical care for people with HIV/AIDS, are also distinguished by their compassionate manner and their wholehearted involvement in the ongoing effort to achieve comprehensive care for persons with HIV/AIDS. 12/2024
- ACTG John Carey Young Investigator Award – Honors an early-career researcher who exemplifies excellence, dedication, and collaborative spirit in advancing HIV research within the AIDS Clinical Trials Group (ACTG). 06/2024
Presentations
- Our division has been exceptionally well represented with major addresses at national and international meetings as well as invited lectureships around the country over the past year.
- These include ID Week and SHEA (Saiman, Frantzis, Zucker), Cystic Fibrosis North American Meeting (Riquelme), Gordon Conferences on Acute Respiratory Infection (Prince) and Immunometabolism (Riquelme).
- Candace Johnson, MD, has also been active in her role in pediatric residency education.
- Banker S, Wilson-Taylor M, Meyers NK, Fuchs J, Johnson CL, Woolard P. “I Highly Recommend”: Mitigating Bias when Writing Effective Letters of Recommendation. Presented at: Pediatric Academic Societies Meeting 2024. 2024 May 2-6; Toronto, Canada
Major Grants
- VZV in the enteric nervous system: pathogenesis and consequences. NIH – NIDDK-5R01DK093094-11. Principal Investigator: Anne Gershon, MD.
- Airway metabolites shape susceptibility to pneumonia. NIH – NHLBI- R01HL170129-01A1. Principal Investigator: Alice Prince, MD.
- Innate immune clearance of host-adapted pulmonary pathogens. NIH – NHLBI R35HL135800-07. Principal Investigator: Alice Prince, MD.
- Impact of nucleotide metabolism on bacterial clearance. NIH- NIGMS. 1R35GM146776-01. Principal Investigator: Sebastian Riquelme Colet, PhD.
- Impact of regulatory T cells on host susceptibility to Pseudomonas aeruginosa infection. NIH-NIAID. 1R21AI181780-01A1. Principal Investigator: Sebastian Riquelme Colet, PhD.
- Assessing Transmission of Influenza within households Using Respiratory Virus Transmission Network (RVTN). CDC. Co-Investigator: Lisa Saiman, MD, MPH.
- Training in pediatric infectious diseases. NIH T32 Training Grant. Principal Investigators: Alice Prince, MD, and Lisa Saiman, MD, MPH.
- Harnessing Bioinformatics for HIV Prevention: Understanding Persistence in Comprehensive HIV Prevention Services. NIH – NIAID. Principal Investigator: Jason Zucker, MD, MS.
- Life after Mpox (LAMP) Study: Clinical, Psychosocial and Behavioral Sequelae of the 2022 Mpox Outbreak in the US. CDC. Principal Investigator: Jason Zucker, MD, MS.
- Assessing the Validity, Reliability and Acceptability of Self-Collected Samples For Mpox Virus Testing In The United States. CDC. Principal Investigator: Jason Zucker, MD, MS. Mpox Viral Persistence. CDC. Principal Investigator: Jason Zucker, MD, MS.
Selected Publications
- Int J Hyg Environ Health. 2024 Jun:259:114357.doi: 10.1016/j.ijheh.2024.114357. Epub 2024 Apr 1. Infection prevention and control and related practices in African neonatal units: The Pan-African neonatal care assessment study (PANCAS). Irene Frantzis 1, Stéphanie Levasseur 2, Jack Huebner 2, Maitry Mahida 2, Philip Larussa 2, Wilmot James 3, Workeabeba Abebe 4, Crispen Ngwenya 5, Ezekiel Mupere 6, Susan L Rosenthal 7, Janna Patterson 8, Julia Johnson 9, Renate Strehlau 10, Sileshi Lulseged 11, Lawrence R Stanberry 2, Lisa Saiman 12
- Staphylococcus aureus adapts to exploit collagen-derived proline during chronic infection. Urso A, Monk IR, Cheng YT, Predella C, Wong Fok Lung T, Theiller EM, Boylan J, Perelman S, Baskota SU, Moustafa AM, Lohia G, Lewis IA, Howden BP, Stinear TP, Dorrello NV, Torres V, Prince AS. Nat Microbiol. 2024 Oct;9(10):2506-2521. doi: 10.1038/s41564-024-01769-9. Epub 2024 Aug 12.PMID: 39134708
- Immunometabolic Regulation of Bacterial Infection, Biofilms, and Antibiotic Susceptibility. Chen YT, Lohia GK, Chen S, Riquelme SA.J Innate Immun. 2024;16(1):143-158. doi: 10.1159/000536649. Epub 2024 Feb 3.PMID: 38310854
- The global role of G6PD in infection and immunity. Shah SS, Stone EF, Francis RO, Karafin MS.Front Immunol. 2024 Jun 13;15:1393213. doi: 10.3389/fimmu.2024.1393213. eCollection 2024.PMID: 38938571
- Incidental identification of neonatal babesiosis: a case report. Tarun S, Mellis IA, Kilic A, Green DA, Tokiwa M, Berry GJ, Wu F, Shah SS.BMC Pediatr. 2024 Nov 27;24(1):776. doi: 10.1186/s12887-024-05219-7.PMID: 39604915
- Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study. Ahmed A, Munoz FM, Muller WJ, Agwu A, Kimberlin DW, Galli L, Deville JG, Sue PK, Mendez-Echevarria A, Humeniuk R, Guo S, Rodriguez L, Han D, Hedskog C, Maxwell H, Palaparthy R, Kersey K, Rojo P; CARAVAN Study Investigators.Pediatrics. 2024 Mar 1;153(3):e2023063775. doi: 10.1542/peds.2023-063775.PMID: 38332740
- Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce. Willis ZI, Oliveira CR, Abzug MJ, Anosike BI, Ardura MI, Bio LL, Boguniewicz J, Chiotos K, Downes K, Grapentine SP, Hersh AL, Heston SM, Hijano DR, Huskins WC, James SH, Jones S, Lockowitz CR, Lloyd EC, MacBrayne C, Maron GM, Hayes McDonough M, Miller CM, Morton TH, Olivero RM, Orscheln RC, Schwenk HT, Singh P, Soma VL, Sue PK, Vora SB, Nakamura MM, Wolf J.J Pediatric Infect Dis Soc. 2024 Mar 19;13(3):159-185. doi: 10.1093/jpids/piad116.PMID: 38339996
- Thomas SJ, Ouellette CP. Viral meningoencephalitis in pediatric solid organ or hematopoietic cell transplant recipients: a diagnostic and therapeutic approach. Front Pediatr. 2024 Feb 12;12:1259088. doi: 10.3389/fped.2024.1259088. PMID: 38410764; PMCID: PMC10895047
- Thomas SJ and Abraham RS. (2024). Laboratory-Based Immune Monitoring in Organ Transplantation. In Chang and Colvin’s Diagnostic Pathology: Transplant Pathology (3rd Edition). Elsevier.
- Zucker J, Caplan AS, Gunaratne SH, Gallitano SM, Zampella JG, Otto C, Sally R, Chaturvedi S, O'Brien B, Todd GC, Anand P, Quilter LAS, Smith DJ, Chiller T, Lockhart SR, Lyman M, Pathela P, Gold JAW. Notes from the Field: Trichophyton mentagrophytes Genotype VII - New York City, April-July 2024. MMWR Morb Mortal Wkly Rep. 2024 Oct 31;73(43):985-988. doi: 10.15585/mmwr.mm7343a5. PMID: 39480750; PMCID: PMC11527365.